Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Headache|June 10, 2004
The medical costs of migraine and comorbid anxiety and depressionJacqueline Pesa, Maureen J LageValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 11, 2005
Relationship between initial quetiapine dose and effectiveness as reflected in subsequent mental health service use among patients with schizophrenia or bipolar disorderFrank Gianfrancesco, Ruey-hua Wang, Jacqueline PesaJournal of Managed Care Pharmacy : JMCP|April 5, 2005
Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapineFrank Gianfrancesco, Jacqueline Pesa, Ruey-Hua WangJournal of Health Economics and Outcomes Research|August 25, 2021
The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic MedicationChristian Frois, Thomas O'Connell, Jacqueline Pesa, et al.Journal of Medical Economics|December 20, 2014
Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychoticsOnur Baser, Lin Xie, Jacqueline Pesa, et al.BMC Rheumatology|February 2, 2022
Depression and food insecurity among patients with rheumatoid arthritis in NHANESQian Cai, Jacqueline Pesa, Ruibin Wang, et al.Journal of Health Economics and Outcomes Research|September 4, 2023
Medicaid Eligibility and Time to Re-incarceration Among Previously Incarcerated Subjects With SchizophreniaChris Kozma, Michael Dickson, Jacqueline Pesa, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 18, 2006
Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study designFrank Gianfrancesco, Jacqueline Pesa, Ruey-Hua Wang, et al.Medicine|February 17, 2023
Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorderJoshua Liberman, Jacqueline Pesa, Pinyao Rui, et al.BMC Psychiatry|June 2, 2022
Factors associated with COVID-19 Infection among a national population of individuals with schizophrenia or schizoaffective disorder in the United StatesJoshua N Liberman, Jacqueline Pesa, Mary Pat Petrillo, et al.Pageof 5